Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial
Creighton Authors
Monk, Bradley J.
Monk, Bradley J.
Admin. Units
School of Medicine; Obstetrics and Gynecology; Gynecological Oncology
School of Medicine; Obstetrics and Gynecology; Gynecological Oncology
Title
Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial
Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial
Authors
Monk, Bradley J.; Poveda, Andrés; Vergote, Ignace; Raspagliesi, Francesco; Fujiwara, Keiichi; Bae, Duk-Soo; Oaknin, Ana; Ray-Coquard, Isabelle; Provencher, Diane M.; Karlan, Beth Y.; Lhommé, Catherine; Richardson, Gary; Rincón, Dolores G.; Coleman, Robert L.; Herzog, Thomas J.; Marth, Christian; Brize, Arija; Fabbro, Michel; Redondo, Andrés; Bamias, Aristotelis; Tassoudji, Marjan; Navale, Lynn; Warner, Douglas J.; Oza, Amit M.
Monk, Bradley J.; Poveda, Andrés; Vergote, Ignace; Raspagliesi, Francesco; Fujiwara, Keiichi; Bae, Duk-Soo; Oaknin, Ana; Ray-Coquard, Isabelle; Provencher, Diane M.; Karlan, Beth Y.; Lhommé, Catherine; Richardson, Gary; Rincón, Dolores G.; Coleman, Robert L.; Herzog, Thomas J.; Marth, Christian; Brize, Arija; Fabbro, Michel; Redondo, Andrés; Bamias, Aristotelis; Tassoudji, Marjan; Navale, Lynn; Warner, Douglas J.; Oza, Amit M.
Journal
Lancet Oncology
Lancet Oncology
Volume
15
Issue
8
Pages
799-808
15
Issue
8
Pages
799-808
Date
2014
2014
Metadata
Show full item record
Link
Check for Full-Text (may not be available)
Check for Full-Text (may not be available)
Citation
Monk, Bradley J.; Poveda, Andrés; Vergote, Ignace; Raspagliesi, Francesco; Fujiwara, Keiichi; Bae, Duk-Soo; Oaknin, Ana; Ray-Coquard, Isabelle; Provencher, Diane M.; Karlan, Beth Y.; Lhommé, Catherine; Richardson, Gary; Rincón, Dolores Gallardo; Coleman, Robert L.; Herzog, Thomas J.; Marth, Christian; Brize, Arija; Fabbro, Michel; Redondo, Andrés; Bamias, Aristotelis; Tassoudji, Marjan; Navale, Lynn; Warner, Douglas J.; Oza, Amit M. Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial. The Lancet Oncology. 2014, 15(8):799-808.
Monk, Bradley J.; Poveda, Andrés; Vergote, Ignace; Raspagliesi, Francesco; Fujiwara, Keiichi; Bae, Duk-Soo; Oaknin, Ana; Ray-Coquard, Isabelle; Provencher, Diane M.; Karlan, Beth Y.; Lhommé, Catherine; Richardson, Gary; Rincón, Dolores Gallardo; Coleman, Robert L.; Herzog, Thomas J.; Marth, Christian; Brize, Arija; Fabbro, Michel; Redondo, Andrés; Bamias, Aristotelis; Tassoudji, Marjan; Navale, Lynn; Warner, Douglas J.; Oza, Amit M. Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial. The Lancet Oncology. 2014, 15(8):799-808.